AL
AdhexPharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Client Development Projects | Various (Confidential) | Not Applicable (CDMO) |
| Zeqmelit® (with AcuCort) | Acute and allergic reactions | Approved/Market-ready |
| BUCCAL-PEP Consortium Project | Peptide analogue delivery via buccal film | Development |
Leadership Team at AdhexPharma
RD
Roland de la Brosse
Founder and President of Adhex group
BL
Bruno Loiseau
Managing Director
MH
Maxime Heraud
Co-Managing Director
AT
Anne-Laure Tedaldi
CMC Development Director
HV
Hugo Vimal
Chief Business Officer
AL
Alain Lambert
Site Director
PD
Pascale Denis
Laboratory Director